The road to refractory graft-versus-host disease is paved with good intentions
Journal article
North D. and Chakraverty R., (2024), Journal of Clinical Investigation, 134
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.
Journal article
Cheminant M. et al, (2022), Blood
CAR-T Cells and Recent Advances in Clinical Cellular Immunotherapy
Chapter
Gu Y. et al, (2022), Practical Transfusion Medicine: Sixth Edition, 543 - 553
Graft Versus Leukaemia (GvL): Identification & Characterisation of Alloreactive Antigens and Cognate T Cell Responses in Acute Myeloid Leukemia
Conference paper
Sweeney C. et al, (2022), BLOOD, 140, 1576 - 1578
Graft-versus-host disease: a disorder of tissue regeneration and repair.
Journal article
Chakraverty R. and Teshima T., (2021), Blood
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Journal article
Marzolini MAV. et al, (2021), Transplant Cell Ther, 27, 682.e1 - 682.e12
Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease
Journal article
Zeiser R. et al, (2021), New England Journal of Medicine, 385, 228 - 238
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Journal article
Schetelig J. et al, (2021), Bone Marrow Transplant, 56, 605 - 613
Graft Versus Leukemia: Current Status and Future Perspectives.
Journal article
O'Neill AT. and Chakraverty R., (2021), J Clin Oncol, 39, 361 - 372
Allogeneic HSCT For Adolescents and Adults With Inborn Errors of Immunity: A Retrospective Study of The Inborn Errors Working Party (IEWP)
Conference paper
Albert M. et al, (2021), BONE MARROW TRANSPLANTATION, 56, 101 - 102
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party (Bone Marrow Transplantation, (2021), 56, 3, (605-613), 10.1038/s41409-020-01069-w)
Journal article
Schetelig J. et al, (2021), Bone Marrow Transplantation
Phenotype Reversal, Excellent Overall, GVHD-free And Graft Failure-Free Survival In 55 Adolescents And Adults With Inborn Errors of Immunity Following Reduced Intensity Allogeneic HSCT
Conference paper
Fox TA. et al, (2021), BONE MARROW TRANSPLANTATION, 56, 103 - 105
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Journal article
Cuadrado MM. et al, (2020), Haematologica, 105, 2639 - 2646
Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
Journal article
Dertschnig S. et al, (2020), J Clin Invest, 130, 1896 - 1911
Very Long-Term Follow Up of 83 Adults WHO Underwent Allogeneic HSCT in Childhood for Primary Immunodeficiency (PID): A Single Centre Experience
Conference paper
Day J. et al, (2020), BONE MARROW TRANSPLANTATION, 55, 106 - 106
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Journal article
Cuadrado MM. et al, (2019), Haematologica
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
Journal article
Sellar RS. et al, (2019), Br J Haematol, 187, e20 - e24
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Journal article
Ferrer IR. et al, (2019), Sci Immunol, 4
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Journal article
Cuff AO. et al, (2019), Front Immunol, 10